21 Results for "

antihyperglycemic agent

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "antihyperglycemic agent" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-B0089
CAS No.: 56180-94-0
Synonyms: BAY g 5421
Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N0547
CAS No.: 1063-77-0
Nomilin is a limonoid compound obtained from the extracts of citrus fruits. Nomilin is an anti-obesity and anti-hyperglycemic agent .
loading...
    loading...
Cat. No.: HY-N7133
CAS No.: 537-67-7
Synonyms: N-Phenylaniline hydrochloride
Diphenylamine hydrochloride (N-Phenylaniline hydrochloride) is an antihyperglycemic agent with oral activity and a common structure in non-steroidal anti-inflammatory drugs (NSAIDs) that uncouples oxidative phosphorylation in mitochondria, leading to a decrease in hepatic cell ATP levels and causing liver cell damage. Diphenylamine hydrochloride is also an industrial antioxidant, a dyeing mordant, and is used in agriculture as an antifungal and antibacterial agent .
loading...
    loading...
Cat. No.: HY-121006
CAS No.: 56-03-1
Purity:  98.07%
Biguanide is an orally active antihyperglycemic agent. Biguanide inhibits mitochondrial ATP production, activates the LKB1-AMPK signaling pathway, and damages the energy homeostasis. Biguanide enhances insulin-receptor activation and downstream signaling. Biguanide exhibits potential in ameliorating the type 2 diabetes and the insulin-associated cancers.
loading...
    loading...
Cat. No.: HY-B0089R
CAS No.: 56180-94-0
Synonyms: BAY g 5421 (Standard)
Acarbose (Standard) is the analytical standard of Acarbose. This product is intended for research and analytical applications. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-146128
CAS No.: 2488372-34-3
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Anti-hyperglycemic agent-1 (compound 10) is a potent α-Glucosidase inhibitor, with an IC50 of 0.53 μM. Anti-hyperglycemic agent-1 can be used for diabetes research .
loading...
    loading...
Cat. No.: HY-N0336A
CAS No.: 72917-31-8
Synonyms: (Z)-Butylidenephthalide
(Z)-3-Butylidenephthalide is an antihyperglycemic agent by inhibiting the activity of intestinal and yeast R-glucosidases (IC50=2.35 mM; Ki=4.86 mM) .
loading...
    loading...
Cat. No.: HY-W197205
CAS No.: 380173-90-0
Research Areas:  

Metabolic Disease

SL010110 is an anti-hyperglycemic agent. SL010110 potently inhibits gluconeogenesis by inhibiting SIRT2, activating p300, and subsequently promoting PEPCK1 degradation. SL010110 downregulates the protein level of PEPCK1 without affecting the gene expressions of PEPCK, glucose-6-phosphatase, and fructose-1,6-bisphosphatase. SL010110 significantly improves glucose homeostasis in type 2 diabetic (T2D) mice model. SL010110 can be used for T2D research .
loading...
    loading...
Cat. No.: HY-178935
CAS No.: 1099611-82-1
α-Amylase-IN-14, a derivative of Nicotinic (HY-B0143), is an α-amylase inhibitor and has good interactions with α-amylase protein (-5.55 kcal/mol). α-Amylase-IN-14 is a dual anti-inflammatory and anti-hyperglycemic agent. α-Amylase-IN-14 exhibits good results against DPPH and ABTS radicals. α-Amylase-IN-14 can be used for the study of diabetes .
loading...
    loading...
Cat. No.: HY-N0547R
CAS No.: 1063-77-0
Nomilin (Standard) is the analytical standard of Nomilin. This product is intended for research and analytical applications. Nomilin is a limonoid compound obtained from the extracts of citrus fruits. Nomilin is an anti-obesity and anti-hyperglycemic agent .
loading...
    loading...
Cat. No.: HY-170943
Target:  

AMPK GLUT

Research Areas:  

Metabolic Disease

Antidiabetic agent 7 (Compound 5m) is hyperglycemic inhibitor. Antidiabetic agent 7 exhibits promising potency to stimulate GLUT4 translocation in skeletal muscle cells via activating AMPK-dependent pathway. Antidiabetic agent 7 reduces blood glucose levels. Antidiabetic agent 7 shows favorable pharmacokinetic properties. Antidiabetic agent 7 is potential to be used for anti-hyperglycemic research .
loading...
    loading...
Cat. No.: HY-B0089A
CAS No.: 1221158-13-9
Synonyms: Bay-g 5421 sulfate
Acarbose (BAY g 5421) sulfate, antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose sulfate can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-19176
CAS No.: 159978-02-6
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

S-15261 is an orally active and potent anti-hyperglycemic agent. S-15261 reduces hepatic glucose production through direct and insulin-sensitizing effects. S-15261 can be used for the research of insulin resistance syndrome .
loading...
    loading...
Cat. No.: HY-121323R
CAS No.: 4430-36-8
Acarbose (Standard) is the analytical standard of Acarbose. This product is intended for research and analytical applications. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-B0089S
CAS No.: 1260619-60-0
Synonyms: BAY g 5421-d4
Acarbose-d4 (BAY g 5421-d4) is deuterium labeled Acarbose. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
loading...
    loading...
Cat. No.: HY-117460
CAS No.: 16112-96-2
Research Areas:  

Others

Indanorex is a stimulant agent with appetite suppressant effects and antihyperglycemic effects .
loading...
    loading...
Cat. No.: HY-N20705
CAS No.: 34202-83-0
Rhamnetin 3-O-rutinoside is an antihyperglycemic agent. Rhamnetin 3-O-rutinoside reduces blood glucose levels. Rhamnetin 3-O-rutinoside decreases serum levels of total cholesterol, triglycerides, urea, creatinine, aspartate aminotransferase (SGOT) and alanine aminotransferase (SGPT). Rhamnetin 3-O-rutinoside can be used in studies related to diabetes .
loading...
    loading...
Cat. No.: HY-184701
α-Glucosidase-IN-119 is an α-glucosidase inhibitor with an IC50 of 3.32 μM and oral effectiveness. α-Glucosidase-IN-119 acts as an antihyperglycemic agent, reduces blood glucose levels, restores normal levels of alkaline phosphatase, aspartate transaminase, alanine transaminase, urea, blood urea nitrogen, and total protein, and exhibits antioxidant activity. α-Glucosidase-IN-119 can be used for the research of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-187872
CAS No.: 1632047-03-0
Uceglifam is an antihyperglycemic agent. Uceglifam can be used in the research of diabetes .
loading...
    loading...
Cat. No.: HY-N7773
CAS No.: 577-24-2
Hibiscetin is an orally active anti-inflammatory, antioxidant, antihyperglycemic, hypolipidemic, hepatoprotective and neuroprotective agent. Hibiscetin reduces the levels of TNF-α, IL-1β and IL-6. Hibiscetin inhibits lipid peroxidation, reduces MDA levels, and induces the activities of antioxidant enzymes CAT, GSH and SOD. Hibiscetin lowers blood glucose, reverses reduced insulin levels, regulates adipokine levels, and reduces elevated AST and ALT levels. Hibiscetin alleviates Rotenone (HY-B1756)-induced akinesia and catalepsy, normalizes neurotransmitter levels, and modulates the activities of activated caspase 3 and BDNF. Hibiscetin can be used in the research of type 2 diabetes, Parkinson's disease and Huntington's disease .
loading...
    loading...